Paying users zone. Data is covered by 
.
Get to Bristol-Myers Squibb Co. for $17.99, or
get to whole website for at least 3 months from $49.99.
Common-Size Income Statement
Difficulty: Beginner
Bristol-Myers Squibb Co., Common-Size Consolidated Income Statement
| 12 months ended | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net product sales | |
|
|
|
|
||||||
| Alliance and other revenues | |
|
|
|
|
||||||
| Revenues | |
|
|
|
|
||||||
| Cost of products sold | |
|
|
|
|
||||||
| Gross margin | |
|
|
|
|
||||||
| Marketing, selling and administrative | |
|
|
|
|
||||||
| Research and development | |
|
|
|
|
||||||
| Operating income | |
|
|
|
|
||||||
| Interest expense | |
|
|
|
|
||||||
| Interest income | |
|
|
|
|
||||||
| Provision for restructuring | |
|
|
|
|
||||||
| Litigation and other settlements | |
|
|
|
|
||||||
| Equity in net income of affiliates | |
|
|
|
|
||||||
| Divestiture gains | |
|
|
|
|
||||||
| Royalties and licensing income | |
|
|
|
|
||||||
| Transition and other service fees | |
|
|
|
|
||||||
| Other alliance and licensing income | |
|
|
|
|
||||||
| Pension charges | |
|
|
|
|
||||||
| Intangible asset impairment | |
|
|
|
|
||||||
| Equity investment impairment | |
|
|
|
|
||||||
| Written option adjustment | |
|
|
|
|
||||||
| Loss on debt redemption | |
|
|
|
|
||||||
| Other | |
|
|
|
|
||||||
| Other income (expense), net | |
|
|
|
|
||||||
| Earnings before income taxes | |
|
|
|
|
||||||
| Provision for income taxes | |
|
|
|
|
||||||
| Net earnings | |
|
|
|
|
||||||
| Noncontrolling interest | |
|
|
|
|
||||||
| Net earnings attributable to BMS | |
|
|
|
|
Based on: 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12), 10-K (filing date: 2015-02-13), 10-K (filing date: 2014-02-14).
| Item | Description | The company |
|---|---|---|
| Operating income | The net result for the period of deducting operating expenses from operating revenues. | Bristol-Myers Squibb Co.'s operating income as a percentage of revenues increased from 2015 to 2016 but then slightly declined from 2016 to 2017 not reaching 2015 level. |
| Earnings before income taxes | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. | Bristol-Myers Squibb Co.'s earnings before income taxes as a percentage of revenues increased from 2015 to 2016 but then slightly declined from 2016 to 2017. |
| Net earnings attributable to BMS | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. | Bristol-Myers Squibb Co.'s net earnings attributable to BMS as a percentage of revenues increased from 2015 to 2016 but then declined significantly from 2016 to 2017. |
